Register entry
Nanjing Xingyin Pharmaceutical Group Co. Ltd.
- Registered sites
- 1
- Drug products
- 3
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Nanjing Xingyin Pharmaceutical Group Co. Ltd. | NanjingChina | Active ingredient (API) manufacture | 3011942686 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Degarelix Acetate | POWDER | BULK INGREDIENT |
| - | Liraglutide | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | sermorelin acetate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.